Agency says the most urgent threats are drug-resistant C diff, Enterobacteriaceae, and gonorrhea.
Resources & Literature
Recent Literature
Iwamoto M, Mu Y, Lynfield R, et al. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics 2013 (published online Sep 23)
Ajao AO, Johnson JK, Harris AD, et al. Risk of acquiring extended-spectrum beta-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit. Infect Control Hosp Epidemiol 2013 May;34(5):453-8
Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013 Jan 9;309(2):163-70
Anderson LF, Tamne S, Watson JP, et al. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill 2013 Oct 3;18(40):pii=20601
Bernard C, Brossier F, Sougakoff W, et al. A surge of MDR and XDR tuberculosis in France among patients born in the former Soviet Union. Euro Surveill 2013 Aug 15;18(33):e20555
Bessesen MT, Lopez K, Guerin K, et al. Comparison of control strategies for methicillin-resistant Staphylococcus aureus. Am J Infect Control 2013 (published online May 9)
Boost MV, Wong A, Ho J, et al. Isolation of methicillin-resistant Staphylococcus aureus (MRSA) from retail meats in Hong Kong. Foodborne Pathog Dis 2013 Jul 24;10(8):705-10
Boucher HW, Talbot GH, Benjamin DK, et al. 10 x '20 progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 2013 Jun 15;56(12):1685-94
Casey JA, Cosgrove SE, Stewart WF, et al. A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010. Epidemiol Infect 2013 (published online Apr 22)
Chen CC, Pass SE. Risk factors for and impact of methicillin-resistant Staphylococcus aureus nasal colonization in patients in a medical intensive care unit. Am J Infect Control 2013 (published online May 9)
Chisholm SA, Unemo M, Quaye N, et al. Molecular epidemiological typing within the European gonococcal antimicrobial resistance surveillance programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013 Jan 17;18(3):pii=20358
Cummings KJ, Perkins GA, Khatibzadeh SM, et al. Antimicrobial resistance trends among Salmonella isolates obtained from dairy cattle in the Northeastern United States, 2004-2011. Foodborne Pathog Dis 2013 Apr 8;10(4):353-61
Dalton T, Cegielski P, Akksilp S, et al. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet Infect Dis 2012 Oct 20;380(9851):1406-17
Das D, Tripura R, Phyo AP, et al. Effect of high dose or split dose artesunate on parasite clearance in artemisinin resistant falciparum malaria. Clin Infect Dis 2012 Mar 1;56(5):e48-58
Decousser JW, Jansen C, Nordmann P, et al. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill 2013 Aug 1;18(31):e20547
Delorenze GN, Horberg MA, Silverberg MJ, et al. Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients. Epidemiol Infect 2013 (published online Feb 18)
Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli infection in the United States. Clin Infect Dis 2013 Mar 1;56(5):641-8
Durante-Mangoni E, Signoriello G, Andini R, et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized, clinical trial. Clin Infect Dis 2013 Aug 1;57(3):349-58
